Arthritis drug approved for polyp prevention blazes trail for other prevention trials

J Natl Cancer Inst. 2000 Feb 16;92(4):297-9. doi: 10.1093/jnci/92.4.297.
No abstract available

Publication types

  • News

MeSH terms

  • Adenomatous Polyposis Coli / drug therapy*
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Anticarcinogenic Agents / therapeutic use*
  • Arthritis / drug therapy
  • Celecoxib
  • Cyclooxygenase 2
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors / therapeutic use*
  • Drug Approval
  • Humans
  • Isoenzymes / pharmacology*
  • Membrane Proteins
  • Prostaglandin-Endoperoxide Synthases / pharmacology*
  • Pyrazoles
  • Sulfonamides / therapeutic use*
  • United States
  • United States Food and Drug Administration

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Anticarcinogenic Agents
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors
  • Isoenzymes
  • Membrane Proteins
  • Pyrazoles
  • Sulfonamides
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases
  • Celecoxib